# Isotopia and Alpha-9 sign lutetium-177 supply agreement

Isotopia Molecular Imaging and Alpha-9 Theranostics signed a global clinical supply agreement for Isotopia's no-carrier-added lutetium-177 for the preclinical and clinical development of Alpha-9's radiopharmaceutical pipeline.

- Type: Contract
- Announced: 2022-05-23
- Status: completed
- Products: lutetium-177 radioisotope, radiopharmaceuticals
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Alpha-9 Theranostics](https://endata.com/companies/61816.md) (customer)
- [Isotopia Molecular Imaging](https://endata.com/companies/63023.md) (supplier)

## Sources

- [a9oncology.com](https://www.a9oncology.com/isotopia-molecular-imaging-and-alpha-9-theranostics-announce-lutetium-177-supply-agreement/), 2022-05-23: "Isotopia Molecular Imaging and Alpha-9 Theranostics, are pleased to announce the signing of a global clinical supply agreement that provides Alpha-9 with Isotopia’s medical radioisotope no-carrier-added lutetium-177 for the preclinical and clinical development of Alpha-9’s radiopharmaceutical pipeli"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.